Status:

RECRUITING

Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo

Lead Sponsor:

Maimonides Medical Center

Collaborating Sponsors:

American Urological Association

Conditions:

Recurrent Urinary Tract Infection

Vaginal Atrophy

Eligibility:

FEMALE

60-90 years

Phase:

PHASE4

Brief Summary

Women over the age of 60 years have an estimated 10 to 15 % risk of recurrent urinary tract infections (UTI). This is believed to be due to hormonally induced changes in the vaginal flora associated w...

Detailed Description

Background: Women over the age of 60 years have an estimated 10 to 15 % risk of recurrent urinary tract infections (UTI). This is believed to be due to hormonally induced changes in the vaginal flora...

Eligibility Criteria

Inclusion

  • 60-90 yo Female
  • Postmenopausal
  • Recurrent UTIs (three or more culture confirmed symptomatic episodes of UTI or two or more in the past 6 months).
  • English Proficiency
  • Unable or unwilling to use topical estrogen.
  • Patients with history of or current endometrial or breast cancer and current aromatase inhibitor therapy may also be included in study.
  • Patient on oral estrogen therapy may be included.
  • Patient with slings, prior vaginal surgery or pessary may be included.

Exclusion

  • Current UTI/ Dipstick and culture positive (\> trace leukocytes or nitrites)
  • Antibiotic (vaginal or oral) use in the last 4 weeks
  • Current sexually transmitted infection
  • Chronic Foley catheter use or chronic ureteral stent placement.
  • Vaginal probiotic use in the last 4 weeks
  • Patient currently using vaginal estrogen.
  • Post-void Residual Volume \>150 mL or current diagnosis of urinary retention
  • Non-evaluated hematuria (\> trace on dipstick, microscopic, gross)
  • Unable to complete study tasks or comply with follow up.

Key Trial Info

Start Date :

November 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04807894

Start Date

November 1 2020

End Date

December 31 2026

Last Update

November 5 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Maimonides Medical Center

Brooklyn, New York, United States, 11219